Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Raymond James Downgrades ZIOPHARM Oncology to Market Perform, Announces $3 Price Target


Benzinga | Aug 10, 2021 05:09AM EDT

Raymond James Downgrades ZIOPHARM Oncology to Market Perform, Announces $3 Price Target

Raymond James analyst David Novak downgrades ZIOPHARM Oncology (NASDAQ:ZIOP) from Outperform to Market Perform and announces $3 price target.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC